We could not find any results for:
Make sure your spelling is correct or try broadening your search.
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners. AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Data show how AbCellera is expanding the reach of T-cell engagers with: CD3-binding antibodies that consistently generate T-cell engagers with potent tumor-cell killing and low cytokine release...
AbCellera (Nasdaq: ABCL) will announce its first quarter 2024 financial results on Tuesday, May 7, 2024, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time...
AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present at the Bloom Burton Healthcare Conference on Tuesday, April 16, 2024, at 7:00 a.m. Pacific Time (10:00 a.m...
AbCellera (Nasdaq: ABCL) and Biogen Inc. (Nasdaq: BIIB) have entered into a strategic collaboration to discover antibodies for a novel target that enables the delivery of biotherapeutics to the...
AbCellera (Nasdaq: ABCL) today announced that its scientists will present four posters with data from its T-cell engager programs and platform at the American Association for Cancer Research...
AbCellera (Nasdaq: ABCL) today announced that Peter Thiel has notified the Company of his intention to resign from the Companyβs Board of Directors for personal reasons, effective March 7, 2024...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.44 | -10.1149425287 | 4.35 | 4.42 | 3.84 | 1082929 | 4.09125837 | CS |
4 | -0.79 | -16.8085106383 | 4.7 | 4.7499 | 3.84 | 1026384 | 4.35204606 | CS |
12 | -1.46 | -27.1880819367 | 5.37 | 5.62 | 3.84 | 1351128 | 4.84368238 | CS |
26 | -0.42 | -9.69976905312 | 4.33 | 6.055 | 3.84 | 1430936 | 4.886198 | CS |
52 | -3.2 | -45.0070323488 | 7.11 | 8.05 | 3.84 | 1948160 | 5.85135473 | CS |
156 | -25.3 | -86.6141732283 | 29.21 | 36.05 | 3.84 | 1977344 | 10.70820117 | CS |
260 | -57.09 | -93.5901639344 | 61 | 71.91 | 3.84 | 1892580 | 12.4916626 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions